Bluejay Diagnostics (BJDX) Change in Account Payables (2020 - 2026)
Bluejay Diagnostics recorded quarterly Change in Account Payables of $6033.0 in Q1 2026, down 88.64% quarter-over-quarter from $53093.0 in Q4 2025, and down 98.39% year-over-year from $374402.0 in Q1 2025.
Bluejay Diagnostics' Change in Account Payables history runs 7 years deep, the most recent figure standing at $6033.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 98.39% year-over-year to $6033.0; the TTM figure through Mar 2026 stood at -$299236.0 (down 220.81% YoY), while the FY2025 annual figure was $69133.0, up 119.96% from the prior year.
- Change in Account Payables came in at $6033.0 for Q1 2026 at Bluejay Diagnostics, down from $53093.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $448199.0 in Q3 2023 to a low of -$520728.0 in Q2 2022.
- A 5-year average of -$12239.1 and a median of $6033.0 in 2026 frame the typical range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 6377.12% in 2022 and fell as far as 789.36% in 2022.
- Bluejay Diagnostics' Change in Account Payables stood at $379948.0 in 2022, then plunged by 166.95% to -$254369.0 in 2023, then surged by 32.57% to -$171528.0 in 2024, then soared by 130.95% to $53093.0 in 2025, then sank by 88.64% to $6033.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $6033.0, $53093.0, and $52345.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | 6,033.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,033.00 |
| Mar 31, 2026 | 6,033.00 |
| Dec 31, 2025 | 53,093.00 |
| Dec 31, 2025 | 53,093.00 |
| Sep 30, 2025 | 52,345.00 |
| Sep 30, 2025 | 52,345.00 |
| Jun 30, 2025 | -410,707.00 |
| Jun 30, 2025 | -410,707.00 |
| Mar 31, 2025 | 374,402.00 |
| Mar 31, 2025 | 374,402.00 |
| Dec 31, 2024 | -171,528.00 |
| Dec 31, 2024 | -171,528.00 |
| Sep 30, 2024 | -173,406.00 |
| Sep 30, 2024 | -173,406.00 |
| Jun 30, 2024 | 218,231.00 |
| Jun 30, 2024 | 218,231.00 |
| Mar 31, 2024 | -219,649.00 |
| Mar 31, 2024 | -219,649.00 |
| Dec 31, 2023 | -254,369.00 |
| Dec 31, 2023 | -254,369.00 |
| Sep 30, 2023 | 448,199.00 |
| Sep 30, 2023 | 448,199.00 |
| Jun 30, 2023 | -114,817.00 |
| Jun 30, 2023 | -114,817.00 |
| Mar 31, 2023 | -314,773.00 |
| Mar 31, 2023 | -314,773.00 |
| Dec 31, 2022 | 379,948.00 |
| Dec 31, 2022 | 379,948.00 |
| Sep 30, 2022 | 18,603.00 |
| Sep 30, 2022 | 18,603.00 |
| Jun 30, 2022 | -520,728.00 |
| Jun 30, 2022 | -520,728.00 |
| Mar 31, 2022 | 421,058.00 |
| Mar 31, 2022 | 421,058.00 |
| Dec 31, 2021 | 5,866.00 |
| Dec 31, 2021 | 5,866.00 |
| Sep 30, 2021 | 13,372.00 |
| Sep 30, 2021 | 13,372.00 |
| Jun 30, 2021 | 75,538.00 |
| Jun 30, 2021 | 75,538.00 |
| Mar 31, 2021 | -173,926.00 |
| Mar 31, 2021 | -173,926.00 |
| Dec 31, 2020 | 133,808.00 |
| Dec 31, 2020 | 133,808.00 |